A First-Time-in-Human Study to Assess the Safety and Tolerability of PP 1420 in Healthy Subjects

NCT01052493 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: PP 1420
DRUG: Placebo

Sponsor

Imperial College London

Collaborators

[object Object]
[object Object]